by Collectif | 13 Jan, 2016 | Bioethics press synthesis | Embryo research and alternatives, Genome
The first genetically modified human embryos could be created in Great Britain within a matter of weeks. Scientists at the Crick Institute in London submitted a request in September 2015. (cf. La Grande Bretagne autorisera-t-elle la manipulation génétique d’embryons...
by Collectif | 13 Jan, 2016 | Bioethics press synthesis | Embryo research and alternatives
Scientists at the EPFL[1]stem cell bioengineering laboratory have succeeded in “transforming adult cells into stem cells using a compression method”.The team led by Professor Lathias Lutolf, has published its results in the Nature Materials journal. They used...
by Collectif | 12 Jan, 2016 | Bioethics press synthesis | MAP – Surrogacy
On 12 January, the regional oncology network, OncoPACA-Corse, announced the birth of the “first baby conceived following oocyte vitrification as part of anticancer treatment”.To date, “according to published data, only six children have been born in the world via this...
by Collectif | 12 Jan, 2016 | Bioethics press synthesis | MAP – Surrogacy
In Quebec, ever since the “abolition of free in-vitro fertilisation treatments last November”, the future of some assisted procreation centres (APCs) is “under threat”, regardless of whether they are public or private. The Ministry for Health “has given...
by Collectif | 12 Jan, 2016 | Bioethics press synthesis | Abortion - Medical termination of Pregnancy(MTP)
Kansas is the eighth State to withdraw Family Planning subsidies since the scandal revealed by the Center for Medical Progress, which highlighted the sale of aborted foetal organs (The Family Planning Association – right at the heart of aborted foetal organ sales)....
by Collectif | 11 Jan, 2016 | Bioethics press synthesis | Embryo research and alternatives
A team of scientists led by Professor Horishi Kawamato from Kyoto University has just announced the launch of a pre-clinical study to develop leukaemia treatment using iPS cells. The team wants to perfect immune system cells derived from iPS cells which, in...